Allena Pharmaceuticals, Inc. (ALNA) |
| 0.075 0.002 (3.16%) 09-07 16:00 |
| Open: | 0.0641 |
| High: | 0.1459 |
| Low: | 0.06 |
| Volume: | 252,311,606 |
| Market Cap: | 0(M) |
| PE Ratio: | -0.12 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
| sell | buy | |||
| Resistance 2: | |
| Resistance 1: | |
| Pivot price: | |
| Support 1: | |
| Support 2: | |
| 52w High: | |
| 52w Low: |
Allena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. Its lead product candidate is ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and gout in the setting of advanced chronic kidney disease. The company was incorporated in 2011 and is headquartered in Newton, Massachusetts.
Financials
| EPS | |
| Book Value | |
| PEG Ratio | |
| Gross Profit |
| Profit Margin (%) | |
| Operating Margin (%) | |
| Return on Assets (ttm) | |
| Return on Equity (ttm) |
Company news
Tue, 24 Mar 2026
252M shares: ALNA Allena Pharmaceuticals NASDAQ close 24 Mar 2026, catalysts soon - Meyka
Thu, 19 Mar 2026
ALNA stock +3.16% intraday on 252,311,606 shares NASDAQ Mar 19 2026: watch cash - Meyka
Thu, 05 Mar 2026
Pre-Market Most Active: ALNA Allena Pharmaceuticals (NASDAQ) $0.075 05 Mar 2026: volume alert - Meyka
Tue, 03 Mar 2026
ALNA (Allena Pharmaceuticals) NASDAQ Pre-Market 03 Mar 2026: $0.08 heavy volume, catalysts ahead - Meyka
Fri, 20 Feb 2026
ALNA (Allena Pharmaceuticals) NASDAQ pre-market $0.08 Feb 20, 2026: heavy volume - Meyka
Tue, 17 Feb 2026
ALNA stock $0.075 pre-market on 252,311,606 volume 17 Feb 2026: watch catalysts - Meyka
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
